[Remdesivir, the antiviral hope against SARS-CoV-2].
Identifieur interne : 003697 ( Ncbi/Curation ); précédent : 003696; suivant : 003698[Remdesivir, the antiviral hope against SARS-CoV-2].
Auteurs : J. Reina [Espagne]Source :
- Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [ 1988-9518 ] ; 2020.
Abstract
On December 31, 2019 a pneumonia outbreak caused by a new coronavirus (SARS-CoV-2) was detected in the city of Wuhan (China). Due to the high capacity of diffusion and human infection it has become a new zoonotic pandemic. The absence of a vaccine has determined the search for antiviral drugs with the capacity to inhibit the replication of the new virus. Among them, remdesivir, an analogue of adenosine, is what seems to have a more promising future. This drug has shown in vitro and in animals a high capacity to block infection and viral replication with attainable concentrations in human plasma. Although all studies have been carried out with SARS-CoV and MERS-CoV, it seems that by virological and functional analogy, remdesivir is one of the few antiviral drugs with proven efficacy. However, studies and clinical trials in humans are required to know the result of their application in them.
DOI: 10.37201/req/098.2020
PubMed: 32239125
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000398
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000398
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000014
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003697
Links to Exploration step
pubmed:32239125Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Remdesivir, the antiviral hope against SARS-CoV-2].</title>
<author><name sortKey="Reina, J" sort="Reina, J" uniqKey="Reina J" first="J" last="Reina">J. Reina</name>
<affiliation wicri:level="1"><nlm:affiliation>Jordi Reina, Unidad de Virología, Servicio de Microbiología, Hospital Universitario Son Espases, Facultad de Medicina (UIB). Carretera Valldemossa 79, 07120 Palma de Mallorca. Spain. jorge.reina@ssib.es.</nlm:affiliation>
<country wicri:rule="url">Espagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32239125</idno>
<idno type="pmid">32239125</idno>
<idno type="doi">10.37201/req/098.2020</idno>
<idno type="wicri:Area/PubMed/Corpus">000398</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000398</idno>
<idno type="wicri:Area/PubMed/Curation">000398</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000398</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000014</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000014</idno>
<idno type="wicri:Area/Ncbi/Merge">003697</idno>
<idno type="wicri:Area/Ncbi/Curation">003697</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Remdesivir, the antiviral hope against SARS-CoV-2].</title>
<author><name sortKey="Reina, J" sort="Reina, J" uniqKey="Reina J" first="J" last="Reina">J. Reina</name>
<affiliation wicri:level="1"><nlm:affiliation>Jordi Reina, Unidad de Virología, Servicio de Microbiología, Hospital Universitario Son Espases, Facultad de Medicina (UIB). Carretera Valldemossa 79, 07120 Palma de Mallorca. Spain. jorge.reina@ssib.es.</nlm:affiliation>
<country wicri:rule="url">Espagne</country>
</affiliation>
</author>
</analytic>
<series><title level="j">Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia</title>
<idno type="eISSN">1988-9518</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">On December 31, 2019 a pneumonia outbreak caused by a new coronavirus (SARS-CoV-2) was detected in the city of Wuhan (China). Due to the high capacity of diffusion and human infection it has become a new zoonotic pandemic. The absence of a vaccine has determined the search for antiviral drugs with the capacity to inhibit the replication of the new virus. Among them, remdesivir, an analogue of adenosine, is what seems to have a more promising future. This drug has shown in vitro and in animals a high capacity to block infection and viral replication with attainable concentrations in human plasma. Although all studies have been carried out with SARS-CoV and MERS-CoV, it seems that by virological and functional analogy, remdesivir is one of the few antiviral drugs with proven efficacy. However, studies and clinical trials in humans are required to know the result of their application in them.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003697 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003697 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:32239125 |texte= [Remdesivir, the antiviral hope against SARS-CoV-2]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:32239125" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |